BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma

被引：0
|
作者：
Christian Monnerat
Agnès Chompret
Caroline Kannengiesser
Marie-Françoise Avril
Nicolas Janin
Alain Spatz
Jean-Marc Guinebretière
Catalin Marian
Michel Barrois
Françoise Boitier
Gilbert M. Lenoir
Brigitte Bressac-de Paillerets
机构：
[1] Institut Gustave Roussy,Department of Genetics
[2] Institut Gustave Roussy,Oncological Genetics, Department of Medicine
[3] Institut Gustave Roussy,Department of Dermatology
[4] Institut Gustave Roussy,Department of Pathology
[5] CHU-Sart-Tilman,Service de Génétique
[6] Hôpital communal,Department of Dermatology
[7] Hôpital Cochin,Department of Pathology
[8] Centre René Huguenin,undefined
来源：
Familial Cancer | 2007年 / 6卷
关键词：
BRCA; TP53; CDKN2A; Melanoma; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 461
页数：8
相关论文
共 50 条
  • [31] BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients
    Alex Friedlaender
    Aurélie Vuilleumier
    Valeria Viassolo
    Aurélie Ayme
    Solène De Talhouet
    Jean-Damien Combes
    Julien Peron
    Alexandre Bodmer
    Sophie Giraud
    Adrien Buisson
    Valerie Bonadona
    Isabelle Gauchat-Bouchardy
    Olivier Tredan
    Pierre O. Chappuis
    S. Intidhar Labidi-Galy
    Breast Cancer Research and Treatment, 2019, 174 : 775 - 783
  • [32] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Alhuqail, Al-Joharah
    Alzahrani, Areej
    Almubarak, Hannah
    Al-Qadheeb, Sarah
    Alghofaili, Lamyaa
    Almoghrabi, Nisreen
    Alhussaini, Hamed
    Park, Ben Ho
    Colak, Dilek
    Karakas, Bedri
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (03) : 695 - 702
  • [33] BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients
    Friedlaender, Alex
    Vuilleumier, Aurelie
    Viassolo, Valeria
    Ayme, Aurelie
    De Talhouet, Solene
    Combes, Jean-Damien
    Peron, Julien
    Bodmer, Alexandre
    Giraud, Sophie
    Buisson, Adrien
    Bonadona, Valerie
    Gauchat-Bouchardy, Isabelle
    Tredan, Olivier
    Chappuis, Pierre O.
    Labidi-Galy, S. Intidhar
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (03) : 775 - 783
  • [34] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Al-Joharah Alhuqail
    Areej Alzahrani
    Hannah Almubarak
    Sarah Al-Qadheeb
    Lamyaa Alghofaili
    Nisreen Almoghrabi
    Hamed Alhussaini
    Ben Ho Park
    Dilek Colak
    Bedri Karakas
    Breast Cancer Research and Treatment, 2018, 168 : 695 - 702
  • [35] BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma
    Pennington, Kathryn P.
    Walsh, Tom
    Lee, Ming
    Pennil, Christopher
    Novetsky, Akiva P.
    Agnew, Kathy J.
    Thornton, Anne
    Garcia, Rochelle
    Mutch, David
    King, Mary-Claire
    Goodfellow, Paul
    Swisher, Elizabeth M.
    CANCER, 2013, 119 (02) : 332 - 338
  • [36] Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia
    Troudi, Wafa
    Uhrhammer, N.
    Sibille, C.
    Dahan, C.
    Mahfoudh, W.
    Souissi, C. Bouchlaka
    Jalabert, T.
    Chouchane, L.
    Bignon, Y. J.
    Ben Ayed, F.
    Elgaaied, A. Ben Ammar
    JOURNAL OF HUMAN GENETICS, 2007, 52 (11) : 915 - 920
  • [37] BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling
    Palmieri, G
    Palomba, G
    Cossu, A
    Pisano, M
    Dedola, MF
    Sarobba, MG
    Farris, A
    Olmeo, N
    Contu, A
    Pasca, A
    Satta, MP
    Persico, I
    Carboni, AA
    Cossu-Rocca, P
    Contini, M
    Mangion, J
    Stratton, MR
    Tanda, F
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1899 - 1907
  • [38] Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives
    Egeli, Unal
    Cecener, Gulsah
    Tunca, Berrin
    Tasdelen, Ismet
    CANCER INVESTIGATION, 2006, 24 (05) : 484 - 491
  • [39] Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia
    Wafa Troudi
    N. Uhrhammer
    C. Sibille
    C. Dahan
    W. Mahfoudh
    C. Bouchlaka Souissi
    T. Jalabert
    L. Chouchane
    Y. J. Bignon
    F. Ben Ayed
    A. Ben Ammar Elgaaied
    Journal of Human Genetics, 2007, 52 : 915 - 920
  • [40] BRCA1 and BRCA2 in Indian Breast Cancer Patients
    Saxena, Sunita
    Szabo, Csilla I.
    Chopin, Sandrine
    Barjhoux, Laure
    Sinilnikova, Olga
    Lenoir, Gilbert
    Goldgar, David E.
    Bhatanager, Dinesh
    HUMAN MUTATION, 2002, 20 (06) : 473 - 474
12345